-
Na LI
Equity Partner / Beijing
-
Tel +86-10-5957-2288
Email lina@zhonglun.com
-
Practices
Chinese Mainland Capital Markets, Investment/M&A & Corporate Governance, Hong Kong & Overseas Capital Markets
-
Industries
Healthcare, Pharmaceuticals & Life Sciences
Na LI
Ms. Li specializes in capital markets, including Chinese mainland capital markets, Hong Kong and overseas capital markets, investment/M&A, and corporate governance. She has represented a wide variety of companies in their enterprise restructuring, mergers and acquisitions, and initial public offerings.
Representative Matters
IPO
Provided legal services for initial public offering to issuers, including Lepu Biopharma (2157.HK), KingMed (603882.SH), Medisan (002900.SZ), Starpower (603290.SH), East Top (002889.SZ), Bomesc (603737.SH), Guizhou BC&TV (600996.SH), Tecon (002100.SZ), Befar Group (601678.SH), Lepu Medical (300003.SZ), Sun Paper (002078.SZ), TRCE (300332.SZ), New China Dragon (603399.SH), and ZMJ (00564.HK)
Refinancing
Advised listed companies on their refinancing in ways of non-public offering, allotment of shares, convertible bonds, and GDR, clients including Lepu Medical (300003.SZ), BGE (603588.SH), BeiLu Pharmaceutical (300016.SZ), Bomesc (603727.SH), Norinco (000065.SZ), BlueFocus (300058.SZ), GCDT (600067.SH), New China Dragon (603399.SH), and Tecon (002100.SZ)
M&A and Restructuring
Provided legal services to Lepu Medical, Lepu Bio, CENBEST, BlueFocus, ZMJ, Poly Group, Dr. Peng Group, and Sunshine Insurance for a variety of merger and acquisition transactions and to Minzu Securities, Tebon Securities, Wuxi Securities, Zhongshan Securities, Jinzhou Securities, and Zhuhai Securities for restructuring
Fund
Provided legal services for equity investment, real estate investment and financing, debt financing to a variety of companies, including CDBC, Boyu Capital, CICC Capital, China Life, CINDA, CITICPE, Shenzhen Capital, and Fortune Capital and advised China Asset Management on its fund projects
Bond
Provided legal services related to issuance of corporate bonds, enterprise bonds, medium-term notes, commercial papers, super & short-term commercial papers, ABS, and ABN to a variety of companies, including Huajin Chem, CSSC, Lepu Medical, HumanWell, BlueFocus, Yangguang, Youzu, China Huaneng, Sinopec, Shandong Energy, and Guotai Junan
Retainer-based Legal Counsel
Acted as retainer-based legal counsel for a variety of listed companies, including Lepu Medicial, Lepu Bio, BGE, Bomesc, and Medisan
Related
-
Deals Related
Zhong Lun advises Lepu Medical's GDR Listing on the SIX Swiss Exchange
Zhong Lun acted as the issuer’s counsel in the listing. Tapping profound professional knowledge and years of experience, the firm rendered high-quality, rigorous and efficient legal services to Lepu Medical.
2022-10-14
-
Bar Admissions/Professional Qualifications
PRC Bar, 2001
Securities Practice Qualification, 2004 -
Education
LL.M. in Civil and Commercial Law, Renmin University of China, 2007
LL.B., Beijing Technology and Business University, 1994-1998 -
Professional Experience
Zhong Lun Law Firm, 2011 to present
DeHeng Law Offices, 2010-2011
Pacific Securities, 2008-2010
DeHeng Law Offices, 1999-2008 -
Languages
Chinese
English